NCT00496353View on ClinicalTrials.gov

MK2461 Phase I/II Study in Patients With Advanced Solid Tumors (MK-2461-002 AM1)(COMPLETED)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

November 30, 2008

Conditions
Neoplasm
Interventions
DRUG

MK2461

MK2461 treatment, bid, 28-day

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00496353 - MK2461 Phase I/II Study in Patients With Advanced Solid Tumors (MK-2461-002 AM1)(COMPLETED) | Biotech Hunter | Biotech Hunter